|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 15738359.7 (espacenet) (Federated) (European Patent Register), 20150716 | Patent/reg. no. and date | DK/EP 3169341, 20190605 | Publication date | 20170524 | Priority no. and date | EP 14306153, 20140716 | EP pub. no. and date |
EP 3169341 20170524 | Effective date | | Applicant/owner | Transgene SA, Parc d'Innovation Boulevard Gonthier d`Andernach
67400 Illkirch Graffenstaden, FR | Applicant ref. no. | P81903039DK00E | Inventor | THIOUDELLET, Christine, 4 boulevard de la Victoire
F-67000 Strasbourg, FR, GEIST, Michel, 18 rue Edouard Manet
F-67170 Brumath, FR, SILVESTRE, Nathalie, 6 rue des Iris
F-67120 Ergersheim, FR, MARCHAND, Jean-Baptiste, 1A rue des Hauts pâturages
F-67210 Obernai, FR, RITTNER, Karola, 51 rue des Pluviers
F-67100 Strasbourg, FR | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 35/768 (2015.01) , C07K 16/18 (2006.01) | Title | ONKOLYTISK VIRUS TIL EKSPRESSION AF IMMUN-CHECKPOINT-MODULATORER | Int. application no. | EP2015066263 | Int. publication no. | WO2016008976 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |